CPT 0557U Vaginitis DNA Panel Reimbursement

CPT code 0557U designates a Proprietary Laboratory Analyses (PLA) molecular test specific to the HealthTrackRx Vaginitis assay from HealthTrackRx and Thermo Fisher Scientific. The test uses real-time DNA amplification to identify bacteria, yeast, parasites, and viruses in vaginal fluid, reporting each organism as detected or not detected. As a PLA code, 0557U applies only to this unique manufacturer-specific test, which matters for laboratory billing, payer coverage decisions, and claims processing across the nation.

Key payers discussed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a national overview of the clinical context for multiplex molecular testing for vaginitis, the implications of PLA coding for lab and payer workflows, common billing modifiers and procedural considerations, and where to find policy and coverage guidance. The publication addresses benchmarks for utilization and payment structures where available and highlights policy or coding issues that affect laboratory reporting and reimbursement for proprietary assays.

This summary is intended for laboratory billing staff, revenue cycle professionals, and payer policy teams seeking a concise reference to CPT code 0557U and its clinical purpose in detecting infectious causes of vaginitis using a targeted DNA amplification panel.

Billing Code Overview

CPT code 0557U is a Proprietary Laboratory Analyses (PLA) code specific to the HealthTrackRx Vaginitis test from HealthTrackRx and Thermo Fisher Scientific. The assay uses real–time DNA amplification to detect DNA from bacteria, yeast, parasites, and viruses in vaginal fluid. Results for each organism tested are reported as either detected or not detected.

Service type: Molecular diagnostic laboratory test (proprietary PCR-based pathogen panel)

Typical site of service: Clinical laboratory or outpatient specimen collection site

Clinical Context

A 28-year-old female presents to an outpatient gynecology clinic with a 5-day history of abnormal vaginal discharge, itching, and vaginal odor. The clinician performs a pelvic exam, collects a vaginal swab, and orders the HealthTrackRx Vaginitis test to identify bacterial, fungal, parasitic, or viral DNA using real-time amplification. The specimen is sent to the performing laboratory (HealthTrackRx/Thermo Fisher Scientific). Results are returned as detected/not detected for each organism and used to differentiate bacterial vaginosis, vulvovaginal candidiasis, trichomoniasis, and other infectious causes to guide targeted therapy.

Coding Specifications

Modifier	Description	When to Use
`00`	Procedure code with no modifier	Use when submitting the PLA test without additional billing modifiers.
`22`	Increased procedural services	Use when test requires substantially greater work or reporting complexity beyond the standard test (rare for an FDA-cleared PLA).
`52`

Taxonomy Code	Specialty	Notes
207Q00000X	Obstetrics & Gynecology	Most common ordering specialty for vaginitis testing.
207L00000X	Family Medicine	Frequently orders vaginitis testing in primary care settings.
207R00000X	Internal Medicine	Orders testing when female patients present with genitourinary symptoms.
364A00000X	Clinical Laboratory	Performing laboratories and pathologists responsible for analyzing specimens.
261QM0800X	Infectious Disease	Consults for recurrent or complicated infections and interpretation of multiplex results.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`N76.0`	Acute vaginitis	Typical indication for ordering a multiplex vaginal pathogen PLA to identify causative organisms.
`N76.1`	Subacute and chronic vaginitis	Used when symptoms are persistent; molecular testing can detect non-culturable organisms.
`N76.2`	Other inflammation of vagina and vulva	Broad category where testing may help determine infectious cause.
`A59.0`	Trichomoniasis	Specific infectious cause detected by DNA amplification on the HealthTrackRx Vaginitis assay.
`B37.3`	Candidiasis of vulva and vagina	Candida species detection is included in the multiplex PLA and guides antifungal therapy.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`87880`	Infectious agent antigen detection by nucleic acid (e.g., direct probe)	Alternative molecular method for detecting specific pathogens; may be ordered if PLA not available.
`88172`	Cytopathology, collection and interpretation (e.g., wet mount)	Wet mount or microscopic exam often performed at point of care alongside molecular testing for immediate clues.
`87070`	Culture, bacterial, any source; supervisory/transfer only	Bacterial culture may be ordered when molecular test results require organism isolation for susceptibility testing.
`87481`	Infectious agent detection by nucleic acid; Chlamydia trachomatis	Specific NAATs for common STIs are often ordered concurrently or instead of a broad PLA.
`87480`	Infectious agent detection by nucleic acid; Trichomonas vaginalis	Targeted NAAT for trichomoniasis commonly performed with vaginitis workup.

OpenPayer

Summary & Overview

CPT 0557U: Vaginitis Pathogen DNA Panel, PCR-Based